From Advocacy to Acceleration: Real-World Levers to De-Risk Development & Expand Access to Personalized Cancer Vaccines
Time: 2:30 pm
day: Conference Day Two
Details:
• Lessons from leading a first-in-human personalized cancer vaccine trial – including key design pivots, unforeseen barriers, and how real-world constraints shaped strategic decision-making
• Strategies to improve patient access in early trials, including compassionate use and advocacy-led engagement to increase awareness and enrollment
• How coalition-led advocacy is reshaping the investment narrative by aligning patient need, early clinical wins, and regulatory flexibility
